We are live on ! Find out more
SAM

Senzar Asset Management Portfolio holdings

AUM $34.7M
1-Year Est. Return 0.56%
This Fund
S&P 500
This Quarter Est. Return
+7.95%
1 Year Est. Return
+0.56%
3 Year Est. Return
-0.75%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$262M
AUM Growth
+$73M
Cap. Flow
+$51.4M
Cap. Flow %
19.63%
Top 10 Hldgs %
65.28%
Holding
27
New
9
Increased
11
Reduced
6
Closed
1

Top Buys

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$13.5M
2
INSM icon
Insmed
INSM
+$12.1M
3
VTRS icon
Viatris
VTRS
+$9.37M
4
MDT icon
Medtronic
MDT
+$8.94M
5
GSK icon
GSK
GSK
+$8.72M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$8.61M
2
AGN
Allergan Inc
AGN
+$7.46M
3
MDVN
MEDIVATION, INC.
MDVN
+$5.68M
4
BIIB icon
Biogen
BIIB
+$5.57M
5
OFIX icon
Orthofix Medical
OFIX
+$3.5M

Sector Composition

Rank Sector Weight
1 Healthcare 81.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
1
Teva Pharmaceuticals
TEVA
$35.4B
$25.7M 9.83%
490,996
+50,596
+11% +$2.59M
SNY icon
2
Sanofi
SNY
$105B
$25.4M 9.72%
478,600
+26,000
+6% +$1.38M
CYH icon
3
Community Health Systems
CYH
$447M
$19.1M 7.3%
509,894
+30,250
+6% +$1.01M
ABBV icon
4
AbbVie
ABBV
$448B
$17.5M 6.67%
309,595
-164,105
-35% -$8.61M
INSM icon
5
Insmed
INSM
$23.3B
$16.4M 6.25%
+818,700
New +$12.1M
QCOR
6
DELISTED
QUESTCOR PHARMA INC
QCOR
$14.6M 5.59%
+158,100
New +$13.5M
OFIX icon
7
Orthofix Medical
OFIX
$449M
$14.2M 5.41%
390,898
-108,200
-22% -$3.5M
AMGN icon
8
Amgen
AMGN
$198B
$14.1M 5.39%
119,298
-8,800
-7% -$1.02M
MDVN
9
DELISTED
MEDIVATION, INC.
MDVN
$12.9M 4.91%
333,668
-168,532
-34% -$5.68M
ENTA icon
10
Enanta Pharmaceuticals
ENTA
$389M
$11M 4.2%
255,128
+114,000
+81% +$4.35M
VTRS icon
11
Viatris
VTRS
$20B
$9.83M 3.76%
+190,700
New +$9.37M
MDT icon
12
Medtronic
MDT
$105B
$9.38M 3.58%
+147,100
New +$8.94M
AGN
13
DELISTED
Allergan Inc
AGN
$8.78M 3.35%
51,900
-47,900
-48% -$7.46M
GSK icon
14
GSK
GSK
$102B
$8.62M 3.29%
+128,880
New +$8.72M
MGLN
15
DELISTED
Magellan Health Services, Inc.
MGLN
$6.74M 2.57%
108,200
+4,800
+5% +$282K
CAH icon
16
Cardinal Health
CAH
$52.8B
$6.56M 2.51%
95,700
+6,600
+7% +$449K
WCG
17
DELISTED
Wellcare Health Plans, Inc.
WCG
$5.91M 2.26%
79,100
-10,000
-11% -$713K
XNPT
18
DELISTED
XENOPORT, INC.
XNPT
$5.66M 2.16%
1,172,700
+385,100
+49% +$1.63M
KYTH
19
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$4.79M 1.83%
124,900
+35,400
+40% +$1.24M
SGNT
20
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$4.74M 1.81%
183,100
+47,700
+35% +$1.06M
MNTA
21
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$4.65M 1.78%
+384,900
New +$4.55M
FPRX
22
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$4.07M 1.56%
262,000
+213,300
+438% +$3.06M
CORI
23
DELISTED
Corium International, Inc.
CORI
$3.98M 1.52%
+511,500
New +$3.86M
RIGL icon
24
Rigel Pharmaceuticals
RIGL
$711M
$3.35M 1.28%
92,320
+50,180
+119% +$1.71M
TLPH icon
25
Talphera
TLPH
$67M
$2M 0.77%
+9,780
New +$1.96M
1
2

Similar funds

BCP
Blum Capital Partners San Francisco, California $34.1M AUM 1.14% 1-Year Est. Return
PRHC
P.R. Herzig & Co Roslyn Heights, New York $45.9M AUM 15.88% 1-Year Est. Return
NAM
Needelman Asset Management Ladera Ranch, California $46M AUM 8.27% 1-Year Est. Return
GG
Gores Group Beverly Hills, California $22.3M AUM 4.58% 1-Year Est. Return
SM
SLS Management New York $17.2M AUM 14.82% 1-Year Est. Return
BC
Breogan Capital New York $56.4M AUM
SCPM
Social Capital PEP Management Palo Alto, California $56.5M AUM
FAM
Fortaleza Asset Management Chicago, Illinois $12.3M AUM 48.33% 1-Year Est. Return

Senzar Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Senzar Asset Management held 27 positions worth $262M, up 39% from $189M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Senzar Asset Management deployed $51.4M of net new capital in Q2 2014, opening 9 new positions and adding to 11 existing holdings. Its largest new stake was QUESTCOR PHARMA INC: 158,100 shares worth $14.6M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 83% a quarter earlier.

On the sell side, the largest reduction was AbbVie, an estimated $8.61M trimmed.

  • Senzar Asset Management's largest Q2 2014 buy was QUESTCOR PHARMA INC: 158,100 shares worth $14.6M.
  • Senzar Asset Management added most to Enanta Pharmaceuticals in Q2 2014, an estimated $4.35M increase.
  • Senzar Asset Management's biggest Q2 2014 reduction was AbbVie, cutting an estimated $8.61M.
  • Senzar Asset Management fully exited Biogen in Q2 2014, selling an estimated $5.57M.
  • Senzar Asset Management's ten largest holdings make up 65% of its $262M portfolio in Q2 2014.
  • Senzar Asset Management opened 9 new positions and closed 1 in Q2 2014.
  • Senzar Asset Management's portfolio value rose 39% quarter-over-quarter to $262M.

Based on Senzar Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.